News
The U.S. Department of Veterans Affairs is taking aim at homelessness and its related issues affecting America's veteran ...
Merus initially surged on superior interim trial data, while Bicara Therapeutics tanked. Click here to find out why BCAX ...
7h
The Nation UAE on MSNDigital smear campaigns threaten IT industry progressPakistan's technology industry, once gaining traction through innovation, talent, and startup grit, is now facing a very different kind of challenge. At first glance, the problem might appear to stem ...
Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...
Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further devel ...
India's digital infrastructure development has been a "game-changer", putting the country ahead of most other nations, ...
“Under no pressure and no response to any protest, they offered themselves a $2 billion commitment to the Black community and Black entrepreneurs, and then after the inauguration of Donald Trump, ...
Sometimes, it's better to wait before expanding a brand into retail. Here is why retail doesn’t build brands, it exposes them.
Tesla ( TSLA 5.66%) stock has tumbled 22% year to date amid a myriad of business and political headwinds, and Wall Street ...
President Trump told reporters this week that he would send letters to trading partners in the next week or two setting ...
TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results